GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CrystalGenomics Invites Co Ltd (XKRX:083790) » Definitions » Cyclically Adjusted Price-to-FCF

CrystalGenomics Invites Co (XKRX:083790) Cyclically Adjusted Price-to-FCF : (As of Jun. 10, 2024)


View and export this data going back to 2006. Start your Free Trial

What is CrystalGenomics Invites Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


CrystalGenomics Invites Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for CrystalGenomics Invites Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CrystalGenomics Invites Co Cyclically Adjusted Price-to-FCF Chart

CrystalGenomics Invites Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CrystalGenomics Invites Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CrystalGenomics Invites Co's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, CrystalGenomics Invites Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CrystalGenomics Invites Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CrystalGenomics Invites Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where CrystalGenomics Invites Co's Cyclically Adjusted Price-to-FCF falls into.



CrystalGenomics Invites Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

CrystalGenomics Invites Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, CrystalGenomics Invites Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-115.503/118.8477*118.8477
=-115.503

Current CPI (Mar. 2024) = 118.8477.

CrystalGenomics Invites Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -43.467 99.353 -51.996
201409 -35.316 99.608 -42.137
201412 -28.323 99.098 -33.968
201503 -37.352 99.720 -44.517
201506 -13.248 100.050 -15.737
201509 14.212 100.110 16.872
201512 -72.203 100.220 -85.623
201603 -97.370 100.560 -115.078
201606 -23.334 100.790 -27.515
201609 -50.543 101.460 -59.205
201612 -28.016 101.560 -32.785
201703 7.725 102.850 8.927
201706 0.910 102.610 1.054
201709 -35.241 103.490 -40.471
201712 -163.806 102.990 -189.028
201803 -49.683 104.100 -56.722
201806 76.421 104.130 87.222
201809 -32.453 105.650 -36.507
201812 -19.471 104.350 -22.176
201903 -8.818 104.490 -10.030
201906 -10.141 104.880 -11.492
201909 -32.267 105.200 -36.453
201912 -80.710 105.120 -91.250
202003 -151.605 105.540 -170.721
202006 -119.713 104.870 -135.669
202009 -77.971 106.200 -87.257
202012 35.740 105.765 40.161
202103 -41.981 107.357 -46.474
202106 -90.776 107.579 -100.285
202109 -125.905 108.759 -137.584
202112 -117.493 109.676 -127.318
202203 -55.624 111.806 -59.127
202206 -142.223 114.083 -148.163
202209 -98.122 114.831 -101.554
202212 -264.675 115.200 -273.055
202303 -122.499 116.550 -124.914
202306 -167.155 117.140 -169.592
202309 -307.731 119.111 -307.050
202312 -168.558 118.848 -168.558
202403 -115.503 118.848 -115.503

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CrystalGenomics Invites Co  (XKRX:083790) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


CrystalGenomics Invites Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of CrystalGenomics Invites Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


CrystalGenomics Invites Co (XKRX:083790) Business Description

Traded in Other Exchanges
N/A
Address
5F, A-dong, Korea Bio Park, 694-1, Sampyeong-dong, Bundang-gu, Seongnam-si, Gyeonggi, KOR, 463-400
CrystalGenomics Invites Co Ltd Formerly CrystalGenomics Inc is one of the leading biopharmaceutical company in Korea. The company is mainly engaged in the research and development and new drug development. It develops innovative new drug development projects such as eradication antibiotics and molecular targeted anticancer drugs. It focuses on arthritic medicines and antibiotics which kill resistant bacteria. It also offers medicines for cancer, obesity, asthma, and diabetes.

CrystalGenomics Invites Co (XKRX:083790) Headlines

No Headlines